Avita Medical, Inc. Common Stock vs. ResMed Inc.
Avita Medical, Inc. Common Stock and ResMed Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| RCEL | RMD | |
|---|---|---|
| Market Cap | $347.00 million | $32.26 billion |
| Revenue (TTM) | $75.63 million | $5.65 billion |
| Net Income (TTM) | $-43,082,000 | $1.52 billion |
RMD leads on 3 of 3 size & scale factors.
Valuation
| RCEL | RMD | |
|---|---|---|
| P/E Ratio | — | 21.28 |
| Price / Book | -12.46 | 4.90 |
| Price / Sales | 4.59 | 5.71 |
RCEL leads on 2 of 2 valuation factors.
Profitability
| RCEL | RMD | |
|---|---|---|
| Net Margin | -56.96% | 26.94% |
| Return on Equity | 154.76% | 23.13% |
RCEL and RMD split the profitability factors evenly.
Dividend
| RCEL | RMD | |
|---|---|---|
| Dividend Yield | — | 1.19% |
| Payout Ratio | — | 25.31 |
RCEL and RMD split the dividend factors evenly.
Risk & Sentiment
| RCEL | RMD | |
|---|---|---|
| Short Interest | 0.34% | 4.04% |
RCEL leads on 1 of 1 risk & sentiment factors.
Dig deeper: RCEL overview, RCEL financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.